Rare Presentation of Adult-Onset Still's Disease Complicated by Acute Severe Hepatitis Refractory to Medical Treatment: A Case Report
- PMID: 40636342
- PMCID: PMC12238314
- DOI: 10.1002/ccr3.70629
Rare Presentation of Adult-Onset Still's Disease Complicated by Acute Severe Hepatitis Refractory to Medical Treatment: A Case Report
Abstract
Managing adult-onset Still's disease complicated by severe hepatitis requires vigilant monitoring and adaptable therapeutic strategies. Standard treatments such as tocilizumab and rituximab can cause adverse reactions or lose efficacy. The interplay of systemic inflammation and liver involvement highlights the need for ongoing research to find effective, safe treatment alternatives.
Keywords: IL‐6 receptor inhibition; adult‐onset Still's disease; rituximab; severe hepatitis; tocilizumab.
© 2025 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials.Rheumatology (Oxford). 2025 Jan 1;64(1):22-31. doi: 10.1093/rheumatology/keae295. Rheumatology (Oxford). 2025. PMID: 38775654
-
Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence.Clin Rheumatol. 2013 Jan;32(1):141-7. doi: 10.1007/s10067-012-2105-2. Epub 2012 Oct 30. Clin Rheumatol. 2013. PMID: 23108887
-
Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review.Semin Arthritis Rheum. 2021 Dec;51(6):1282-1290. doi: 10.1016/j.semarthrit.2021.08.007. Epub 2021 Aug 27. Semin Arthritis Rheum. 2021. PMID: 34493394
-
[Siltuximab as a salvage therapy in multi-refractory adult-onset Still's disease: A case series].Rev Med Interne. 2025 Jul;46(7):415-420. doi: 10.1016/j.revmed.2025.05.002. Epub 2025 May 23. Rev Med Interne. 2025. PMID: 40413088 French.
-
[Systemic juvenile idiopathic arthritis. Pediatric-onset Still's disease].Rev Prat. 2024 Dec;74(10):1076-1081. Rev Prat. 2024. PMID: 40546196 Review. French.
References
-
- Efthimiou P., Kontzias A., Hur P., Rodha K., Ramakrishna G. S., and Nakasato P., “Adult‐Onset Still's Disease in Focus: Clinical Manifestations, Diagnosis, Treatment, and Unmet Needs in the Era of Targeted Therapies,” Seminars in Arthritis and Rheumatism 51, no. 4 (2021): 858–874, 10.1016/j.semarthrit.2021.06.004. - DOI - PubMed
-
- Tirotta D., Lena C., Guasti P., and Muratori P., “Acute Hepatitis in Adult‐Onset Still's Disease: Four Presentation Pattern Proposed,” Journal of Clinical Medical Images 7, no. 8 (2023): 1–10.
-
- Bilgin E., Hayran M., Erden A., et al., “Correction to: Proposal for a Simple Algorithm to Differentiate Adult‐Onset Still's Disease With Other Fever of Unknown Origin Causes: A Longitudinal Prospective Study,” Clinical Rheumatology 38, no. 4 (2019): 1193–1194, 10.1007/s10067-019-04479-4. - DOI - PubMed
-
- Fautrel B., Zing E., Golmard J. L., et al., “Proposal for a New Set of Classification Criteria for Adult‐Onset Still Disease,” Medicine (Baltimore) 81, no. 3 (2002): 194–200. - PubMed
LinkOut - more resources
Full Text Sources